These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3038956)

  • 21. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
    Richman DD; Kornbluth RS; Carson DA
    J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human T-cell leukemia virus type 1 replication by antisense env oligodeoxynucleotide.
    Maeda N; Kawamura T; Hoshino H; Yamada N; Blackard J; Kushida S; Miyano-Kurosaki N; Yamamoto N; Makino K; Yokota T; Uchida K; Miwa M
    Biochem Biophys Res Commun; 1998 Feb; 243(1):109-12. PubMed ID: 9473488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pX region of HTLV-I.
    Hatanaka M; Kobayashi N
    Princess Takamatsu Symp; 1984; 15():205-17. PubMed ID: 6100640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response.
    Andrews JM; Oglesbee MJ; Trevino AV; Guyot DJ; Newbound GC; Lairmore MD
    Virology; 1995 Apr; 208(2):816-20. PubMed ID: 7747457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression.
    Shaw GM; Broder S; Essex M; Gallo RC
    Adv Intern Med; 1984; 30():1-27. PubMed ID: 6084947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by human T-lymphotropic virus (HTLV-I) of T-lymphocyte mitogenesis: failure of exogenous T-cell growth factor to restore responsiveness to lectin.
    Wainberg MA; Spira B; Boushira M; Margolese RG
    Immunology; 1985 Jan; 54(1):1-7. PubMed ID: 2982729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
    Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
    Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
    Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
    Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of 3'-azido-2',3'-dideoxythymidine on experimental viral infections].
    Shneĭder MA; Rudenko NK; Kavsan VM; Bibilashvili RSh; Kraevskiĭ AA
    Mol Biol (Mosk); 1987; 21(3):837-46. PubMed ID: 2821379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
    Balzarini J; Mitsuya H; De Clercq E; Broder S
    Int J Cancer; 1986 Mar; 37(3):451-7. PubMed ID: 2419266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
    Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
    Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus.
    Pauwels R; De Clercq E; Desmyter J; Balzarini J; Goubau P; Herdewijn P; Vanderhaeghe H; Vandeputte M
    J Virol Methods; 1987 Jun; 16(3):171-85. PubMed ID: 2821048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine.
    Chandra P; Sarin PS
    Arzneimittelforschung; 1986 Feb; 36(2):184-6. PubMed ID: 3008768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferons inhibit syncytia-forming ability and in vitro transmission of human T-cell leukemia virus.
    Nishida J; Yoshikura H; Okabe T; Urabe A; Takaku F
    Jpn J Cancer Res; 1985 Apr; 76(4):249-52. PubMed ID: 2989059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
    Yarchoan R; Klecker RW; Weinhold KJ; Markham PD; Lyerly HK; Durack DT; Gelmann E; Lehrman SN; Blum RM; Barry DW
    Lancet; 1986 Mar; 1(8481):575-80. PubMed ID: 2869302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.
    Cooney DA; Dalal M; Mitsuya H; McMahon JB; Nadkarni M; Balzarini J; Broder S; Johns DG
    Biochem Pharmacol; 1986 Jul; 35(13):2065-8. PubMed ID: 3015143
    [No Abstract]   [Full Text] [Related]  

  • 38. Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.
    Vogt MW; Durno AG; Chou TC; Coleman LA; Paradis TJ; Schooley RT; Kaplan JC; Hirsch MS
    J Infect Dis; 1988 Aug; 158(2):378-85. PubMed ID: 2841378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species.
    Balzarini J; Pauwels R; Baba M; Herdewijn P; de Clercq E; Broder S; Johns DG
    Biochem Pharmacol; 1988 Mar; 37(5):897-903. PubMed ID: 2830886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
    De Clercq E
    J Med Chem; 1986 Sep; 29(9):1561-9. PubMed ID: 2427720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.